Fda form 3926-2026

1. Click ‘Get Form’ to open it in the editor.
2. In Box 1, enter the patient’s initials and the date of submission. This ensures confidentiality while documenting your request.
3. For Box 2, provide detailed clinical information including the indication, a brief clinical history (age, gender, weight, allergies), and rationale for requesting treatment. This section is crucial for justifying the need for expanded access.
4. In Box 3, specify the investigational drug's name and outline the treatment plan. Include details such as dosage, route of administration, duration of treatment, and monitoring procedures.
5. If applicable, attach a Letter of Authorization (LOA) from the drug manufacturer in Box 4. This allows FDA to reference necessary information regarding the drug.
6. Complete Box 5 with your qualifications as a physician. You may attach your CV if preferred.
7. Fill in your contact information in Box 6 to ensure FDA can reach you easily regarding your application.
8. In Box 7, request authorization to use Form FDA 3926 for compliance with IND submission requirements.
9. Finally, sign and date Box 8 certifying that you will not begin treatment until receiving FDA notification or after 30 days.

Start using our platform today to streamline your form completion process for free!